Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 7 - Drugs for disorders of the blood or the extracellular fluid
Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065)
10/2000
10/17/2000US6133262 3-aminobenzo(b)thiophene derivatives
10/17/2000US6133256 Selective factor Xa inhibitors
10/17/2000US6133013 Nucleotide sequence coding protein with clot dissolving activity; for treatment blood coagulation defects
10/17/2000US6133011 Chimeric proteins having fibrinolytic and thrombin-inhibiting properties
10/17/2000US6132991 Human interleukin-3 (IL-3) variant fusion proteins
10/17/2000US6132730 Combined tissue factor and factor VIIa methods and compositions for coagulation and tumor treatment
10/17/2000US6132729 Coagulation-deficient tissue factor for use in effecting specific coagulation and for use in tumor treatment
10/17/2000CA2196308C Peptide, bronchodilator and blood flow ameliorant
10/17/2000CA2178752C N-terminally chemically modified protein compositions and methods
10/12/2000WO2000060082A2 Vesicle associated proteins
10/12/2000WO2000060080A2 Molecules of the immune system
10/12/2000WO2000059941A1 Purposeful movement of human migratory cells away from an agent source
10/12/2000WO2000059903A1 Universal die holder assembly for press brakes
10/12/2000WO2000059901A1 Substituted 1,4-dihydroindeno[1,2-c]pyrazoles as inhibitors of tyrosine kinase
10/12/2000WO2000059888A1 N-benzimidazolylmethyl- and n-indolylmethyl-benzamides and their use as crf modulators
10/12/2000WO2000059876A1 3-amidinobenzenesulfonamide derivatives, medicinal compositions containing the same and intermediates in the production thereof
10/12/2000WO2000059874A1 NOVEL AMIDE DERIVATIVES AS INHIBITORS OF MATRIX METALLOPROTEINASES, TNF-α, AND AGGRECANASE
10/12/2000WO2000059855A1 Ether compounds, compositions, and uses thereof
10/12/2000WO2000059535A2 suPAR STIMULATING ACTIVITY OF tcuPA-MEDIATED FIBRINOLYSIS AND DIFFERENT USES THEREOF
10/12/2000WO2000059493A2 Improved dialysis solutions and methods
10/12/2000WO2000059483A2 Transdermal drug delivery devices comprising a polyurethane drug reservoir
10/12/2000WO2000059448A2 Association of no-synthase inhibitor(s) and metabolic antioxidant(s)
10/12/2000DE19915862A1 Verwendung von molekulargewichtserweitertem Hirudin als Antikoagulans bei der extrakorporalen Nierenersatztherapie Use of molekulargewichtserweitertem hirudin as an anticoagulant in extracorporeal renal replacement therapy
10/12/2000DE10004815A1 Human sodium-phosphate cotransporter Npt2B, useful e.g. for identifying agents for treating hyper- and hypo-phosphatemia, and related nucleic acid
10/12/2000CA2369553A1 N-benzimidazolylmethyl and n-indolylmethyl-benzamides and their use as crf modulators
10/12/2000CA2368686A1 Substituted 1,4-dihydroindeno[1,2-c]pyrazoles as inhibitors of tyrosine kinase
10/12/2000CA2368623A1 3-amidinobenzenesulfonamide derivatives, medicinal compositions containing the same and intermediates in the production thereof
10/12/2000CA2368183A1 Supar stimulating activity of tcupa-mediated fibrinolysis and different uses thereof
10/12/2000CA2367378A1 Molecules of the immune system
10/12/2000CA2367100A1 Transdermal drug delivery devices comprising a polyurethane drug reservoir
10/12/2000CA2366264A1 Novel amide derivatives as inhibitors of matrix metalloproteinases, tnf-.alpha., and aggrecanase
10/12/2000CA2365500A1 Association of no-synthase inhibitor(s) and metabolic antioxidant(s)
10/12/2000CA2365421A1 Vesicle associated proteins
10/11/2000EP1043310A1 Biphenylamidine derivatives
10/11/2000EP1042674A1 148 human secreted proteins
10/11/2000EP1042299A1 Nitrogen containing heteroaromatics with ortho-substituted p1's as factor xa inhibitors
10/11/2000EP1042287A1 Indole derivatives as inhibitors of factor xa
10/11/2000CN1269214A Thrombus dissolving capsule
10/11/2000CN1057292C Dicyclic compound, medicinal composition containing same and use thereof
10/11/2000CN1057224C Rendu kidney-tonifying wine
10/11/2000CN1057212C Oral liquor for body-building
10/11/2000CN1057208C Use of rhodiola-root extract in medicine of promoting lukoblastosis
10/10/2000US6130231 Integrin receptor antagonists
10/10/2000US6130208 Formulation containing a nucleotide analogue
10/10/2000US6130060 Gene encoding for adseverin
10/10/2000CA2126648C Liposomes containing bioavailable iron (ii) and method for obtaining them
10/05/2000WO2000058513A1 49 human secreted proteins
10/05/2000WO2000058496A1 50 human secreted proteins
10/05/2000WO2000058495A1 45 human secreted proteins
10/05/2000WO2000058494A1 50 human secreted proteins
10/05/2000WO2000058483A2 Protozoan expression system
10/05/2000WO2000058473A2 Nucleic acids including open reading frames encoding polypeptides; 'orfx'
10/05/2000WO2000058468A2 47 human secreted proteins
10/05/2000WO2000058467A1 50 human secreted proteins
10/05/2000WO2000058361A1 Melanocortin receptor ligands
10/05/2000WO2000058356A1 50 human secreted proteins
10/05/2000WO2000058355A1 50 human secreted proteins
10/05/2000WO2000058341A1 Hookworm platelet inhibitor
10/05/2000WO2000058339A2 50 human secreted proteins
10/05/2000WO2000058334A1 50 human secreted proteins
10/05/2000WO2000058295A2 Compounds and methods for treatment of asthma, allergy and inflammatory disorders
10/05/2000WO2000057920A2 Method for expressing proteins
10/05/2000WO2000057903A2 48 human secreted proteins
10/05/2000WO2000057901A1 Modulation of vascular permeability by means of tie2 receptor activators
10/05/2000WO2000057884A1 Medicinal preparation containing at least in part acetylsalicylic acid as active ingredient
10/05/2000CA2383592A1 2384891 acids including open reading frames encoding polypeptides; orfx
10/05/2000CA2370441A1 50 human secreted proteins
10/05/2000CA2369458A1 47 human secreted proteins
10/05/2000CA2368951A1 50 human secreted proteins
10/05/2000CA2368927A1 45 human secreted proteins
10/05/2000CA2368881A1 50 human secreted proteins
10/05/2000CA2368719A1 50 human secreted proteins
10/05/2000CA2368700A1 49 human secreted proteins
10/05/2000CA2368489A1 50 human secreted proteins
10/05/2000CA2368467A1 50 human secreted proteins
10/05/2000CA2368442A1 48 human secreted proteins
10/05/2000CA2368281A1 50 human secreted proteins
10/05/2000CA2368113A1 Protozoan expression system
10/05/2000CA2368090A1 Compounds and methods for treatment of asthma, allergy and inflammatory disorders
10/05/2000CA2367424A1 Hookworm platelet inhibitor
10/05/2000CA2366305A1 Method for expressing proteins
10/04/2000EP1040112A1 Imidazonaphthyridines and their use in inducing cytokine biosynthesis
10/04/2000EP1040108A1 Ortho-anthranilamide derivatives as anti-coagulants
10/04/2000EP1040100A1 Therapeutically active compounds based on indazole bioisostere replacement of catechol in pde4 inhibitors
10/04/2000EP1039919A1 Composition for improving mental capabilities in mammals
10/04/2000EP1039917A1 Pharmaceutical composition comprising ticlopidine and ginkgo biloba extract
10/04/2000EP1039911A1 MORPHOLINO-N-ETHYL ESTER PRODRUGS OF INDOLE sPLA 2 INHIBITORS
10/04/2000EP1039907A1 Thrombin inhibitors
10/04/2000EP1039906A1 Novel metal complexes
10/04/2000EP1039903A1 Il-8 receptor antagonists
10/04/2000EP1039893A1 Pharmaceutical compositions containing an omega-3 fatty acid oil
10/04/2000CN1269013A Moleculars withch give out multiple active parts
10/04/2000CN1268891A Dietary supplements contg. natural ingredients
10/04/2000CN1268376A Medicine preparation containing glucokinase and its preparation method
10/04/2000CN1268374A New type hemostat
10/04/2000CN1057124C Bifunctional variants of urokinase with improved fibrinolytic properties and thrombin-inhibiting activity
10/04/2000CN1057083C Tricyclic 1-aminoethylpyrrol derivative
10/04/2000CN1057005C Application of theaflavine for preparing medicine for treating leukopenia disease
10/04/2000CN1057004C Application of theaflavine for prepn. of medicine for treating cerebral infarction
10/03/2000US6127376 Aryl and heterocyclyl substituted pyrimidine derivatives as anti-coagulants
1 ... 511 512 513 514 515 516 517 518 519 520 521 522 523 524 525 526 527 528 529 530 531 ... 671